TGF-b (Inventiva)

N/A

Report date: 2025/03/19 18:26:11
NME

Base Information

Drug NameTGF-b (Inventiva)
Drug Alias NameGEV (Inventiva/Boehringer)fibrosis program (Inventiva/Boehringer Ingelheim)fibrosis program (Inventiva)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTransforming growth factor beta 1 modulators
TargetsTransforming growth factor beta 1
Therapy Area/IndicationsFibrosisIdiopathic Pulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInventiva SA
China Registration ClassN/A

Develop Information

Active CompaniesInventiva SA
Inactive CompaniesBoehringer Ingelheim International Gmbh
Active IndicationsFibrosisIdiopathic Pulmonary Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A